EP0804453A4 - Procede de detection et de traitement du cancer du sein - Google Patents

Procede de detection et de traitement du cancer du sein

Info

Publication number
EP0804453A4
EP0804453A4 EP95910094A EP95910094A EP0804453A4 EP 0804453 A4 EP0804453 A4 EP 0804453A4 EP 95910094 A EP95910094 A EP 95910094A EP 95910094 A EP95910094 A EP 95910094A EP 0804453 A4 EP0804453 A4 EP 0804453A4
Authority
EP
European Patent Office
Prior art keywords
detection
treatment
breast cancer
breast
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95910094A
Other languages
German (de)
English (en)
Other versions
EP0804453A1 (fr
Inventor
Jeffrey T Holt
Roy A Jensen
David L Page
Patrice S Obermiller
Cheryl L Robinson-Benion
Marilyn E Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vanderbilt University
Original Assignee
Vanderbilt University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanderbilt University filed Critical Vanderbilt University
Priority claimed from PCT/US1995/000608 external-priority patent/WO1995019369A1/fr
Publication of EP0804453A1 publication Critical patent/EP0804453A1/fr
Publication of EP0804453A4 publication Critical patent/EP0804453A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
EP95910094A 1995-01-17 1995-01-17 Procede de detection et de traitement du cancer du sein Withdrawn EP0804453A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US373799 1989-06-29
US37379995A 1995-01-17 1995-01-17
PCT/US1995/000608 WO1995019369A1 (fr) 1994-01-14 1995-01-17 Procede de detection et de traitement du cancer du sein

Publications (2)

Publication Number Publication Date
EP0804453A1 EP0804453A1 (fr) 1997-11-05
EP0804453A4 true EP0804453A4 (fr) 2004-08-11

Family

ID=23473920

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95910094A Withdrawn EP0804453A4 (fr) 1995-01-17 1995-01-17 Procede de detection et de traitement du cancer du sein

Country Status (3)

Country Link
EP (1) EP0804453A4 (fr)
AU (1) AU707348B2 (fr)
CA (1) CA2210396A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69521002T3 (de) * 1994-08-12 2010-02-25 The University Of Utah Research Foundation, Salt Lake City Mutationen des mit 17q verbundenen Ovarial- und Brustkrebs Empfindlichkeitsgens

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994006910A1 (fr) * 1992-09-18 1994-03-31 Canji, Inc. Therapie genique au moyen d'un vecteur retroviral a gene de suppression tumorale
WO1994016080A1 (fr) * 1993-01-08 1994-07-21 Exemplar Corporation Procede in vitro/in vivo d'identification de medicaments anti-neoplasiques
EP0705903A1 (fr) * 1994-08-12 1996-04-10 Myriad Genetics, Inc. Mutations in vivo et polymorphismes du gène de susceptibilité associé au cancer du sein et des ovaires associé au 17Qq

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994006910A1 (fr) * 1992-09-18 1994-03-31 Canji, Inc. Therapie genique au moyen d'un vecteur retroviral a gene de suppression tumorale
WO1994016080A1 (fr) * 1993-01-08 1994-07-21 Exemplar Corporation Procede in vitro/in vivo d'identification de medicaments anti-neoplasiques
EP0705903A1 (fr) * 1994-08-12 1996-04-10 Myriad Genetics, Inc. Mutations in vivo et polymorphismes du gène de susceptibilité associé au cancer du sein et des ovaires associé au 17Qq

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BROWN M A ET AL: "Regulation of BRCA1.", NATURE. ENGLAND 1994 DEC 22-29, vol. 372, no. 6508, 22 December 1994 (1994-12-22), pages 733, XP002283560, ISSN: 0028-0836 *
KUMAR C C: "SETTING UP REPORTER-GENE BASED ASSAY SYSTEMS FOR SCREENING ANTINEOPLASTIC DRUGS", PHARMACEUTICAL TECHNOLOGY, EUGENE, OR, US, vol. 15, June 1991 (1991-06-01), pages 26 - 28,32-34, XP009010062 *
See also references of WO9519369A1 *
THOMPSON M E ET AL: "DECREASED EXPRESSION OF BRCA1 ACCELERATES GROWTH AND IS OFTEN PRESENT DURING SPORADIC BREAST CANCER PROGRESSION", NATURE GENETICS, NEW YORK, NY, US, vol. 9, no. 4, April 1995 (1995-04-01), pages 444 - 450, XP001011260, ISSN: 1061-4036 *

Also Published As

Publication number Publication date
CA2210396A1 (fr) 1995-07-20
AU1831795A (en) 1995-08-01
EP0804453A1 (fr) 1997-11-05
AU707348B2 (en) 1999-07-08

Similar Documents

Publication Publication Date Title
EP0831904A4 (fr) Traitement et diagnostic du cancer de la prostate
AU6062096A (en) Method and apparatus for therapeutic electromagnetic treatment
GB2307235B (en) Water treatment process and system
HUP9902068A3 (en) Methods and compositions for the diagnosis and treatment of cancer
AP9700939A0 (en) Compounds and methods for the treatment of cancer
AU6446496A (en) Method and apparatus for treatment of cancer using pulsed electromagnetic radiation
HK1010081A1 (en) Methods of preventing or treating allergies
GB9701930D0 (en) Tissue processing apparatus and method
EP0810860A4 (fr) Procede et utilisation du radicicol pour le traitement de l'inflammation et de l'endotoxemie
AU1980995A (en) Methods and compositions for treatment of breast cancer
AU7012496A (en) Compounds and methods for treatment and diagnosis of prostate cancer
AU6592390A (en) Method and apparatus for the treatment of cancer
AU6328196A (en) Targets for breast cancer diagnosis and treatment
EP0874609A4 (fr) Vetements medicaux therapeutiques pour les cicatrices et procede afferent
EP0735054A3 (fr) Méthode de psot-traitement de polyoléfines modifiées
GB2318734B (en) Methods of preventing breast cancer
AU8259798A (en) Method for detection of breast cancer
EP0819951A4 (fr) Procede et dispositif de detection de diastrophisme
EP0828507A4 (fr) Technique de traitement de la douleur
EP0804453A4 (fr) Procede de detection et de traitement du cancer du sein
GB9507825D0 (en) Method of treatment
EG20694A (en) Process for treatment of afluid and apparatus therefor
EP0918532A4 (fr) Nouveau procede de detection et de traitement du cancer
EP0987943A4 (fr) Nouvelle methode de detection et de traitement de cancer
GB9523341D0 (en) Method and apparatus for water treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970806

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/47 B

Ipc: 7G 01N 33/574 B

Ipc: 7C 12Q 1/68 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040629

17Q First examination report despatched

Effective date: 20040923

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060303